Package 60760-382-14

Brand: oxaprozin

Generic: oxaprozin
NDC Package

Package Facts

Identity

Package NDC 60760-382-14
Digits Only 6076038214
Product NDC 60760-382
Description

14 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (60760-382-14)

Marketing

Marketing Status
Marketed Since 2022-08-15
Brand oxaprozin
Generic oxaprozin
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "46284e55-cb54-f3f4-e063-6394a90a201b", "openfda": {"nui": ["N0000000160", "M0001335", "N0000175722"], "unii": ["MHJ80W9LRB"], "rxcui": ["312132"], "spl_set_id": ["e881dca6-004e-1c3e-e053-2a95a90a02ab"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "manufacturer_name": ["ST MARY'S MEDICAL PARK PHARMACY"]}, "finished": true, "packaging": [{"sample": false, "description": "14 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (60760-382-14)", "package_ndc": "60760-382-14", "marketing_start_date": "20220815"}], "brand_name": "Oxaprozin", "product_id": "60760-382_46284e55-cb54-f3f4-e063-6394a90a201b", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Cyclooxygenase Inhibitors [MoA]", "Nonsteroidal Anti-inflammatory Drug [EPC]"], "product_ndc": "60760-382", "generic_name": "Oxaprozin", "labeler_name": "ST MARY'S MEDICAL PARK PHARMACY", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Oxaprozin", "active_ingredients": [{"name": "OXAPROZIN", "strength": "600 mg/1"}], "application_number": "ANDA075855", "marketing_category": "ANDA", "marketing_start_date": "20220815", "listing_expiration_date": "20261231"}